About us
Company: Shinsei Capital Partners, Ltd.
Founded: April 18, 2018
Management: CEO Manabu Nakamura
Director Yoshiyuki Yamakawa (President/Representative Director, HIBIKI Partners)
Director Nobuyuki Hata (Professor, Graduate Institute for Entrepreneurial Studies)
Director Genichi Minowa (CFO, Shinsei Corporate Investment)
Auditor Fuyuki Kojima (Partner attorney, HIFUMI Law)
Auditor Yutaka Kato (Senior Manager, Shinsei Bank Venture Business Division)
Fund: New Life Science I Investment Limited Partnership
Founded: February 7, 2019
Fund Size: JPY 10.1 billion yen (Final close at February 6, 2020)
GP: New Life Science I LLP

History
July 2004 Shinsei Bank started Pre-IPO investment in Private Equity division
November 2012 Established
Shinsei Corporate Investment as a Private Equity
investment arm of Shinsei Bank
Invested in 76 companies over 14 years from 2004 to 2018, and
26 of which succeeded in IPO
Investment Team in Shinsei Corporate Investment